Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial

BACKGROUND: Chronic kidney disease with metabolic acidosis is common in older people, but the effectiveness of oral sodium bicarbonate therapy in this group is unclear. We tested whether oral sodium bicarbonate provides net health benefit for older people with advanced chronic kidney disease and ser...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144058/
https://www.ncbi.nlm.nih.gov/pubmed/32268897
http://dx.doi.org/10.1186/s12916-020-01542-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144058/
https://www.ncbi.nlm.nih.gov/pubmed/32268897
http://dx.doi.org/10.1186/s12916-020-01542-9

Ejemplares similares